Primary breast tumor characteristics predicting aggressive nodal involvement

American Journal of Surgery

Volumn 194, Issue 4, 2007, Pages 474-476

  Ma, Aye Moe Thu ^a   Bowling, Monet ^a   Leitch, Marilyn ^a   Rao, Roshni ^a   Euhus, David M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

10 axillary lymph nodes; Breast neoplasms mortality; Breast neoplasms pathology; Carcinoma mortality; Lymphatic metastasis; Prognosis; Survival rate

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INVASION; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; INFLAMMATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES;

EID: 34548448411     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2007.06.009     Document Type: Article

References (8)

1. Nemoto T., Vana J., Bedwani R.N., et al. Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer 45 (1980) 2917-2924
2. Wilson R.E., Donegan W.L., Mettlin C., et al. The 1982 survey of carcinoma of the breast in the United States by the American College of Surgeons. Surg Gynecol Obstet 159 (1984) 309-319
3. Allan A.L., George R., Vantyghem S.A., et al. Role of the integrin-binding protein osteopontin in lymphatic metastatis of breast cancer. Am J Pathol 169 (2006) 233-246
4. Alpaugh M.L., Tomlinson J.S., Shao Z.M., and Barsky S.H. A noval human xenograft model of inflammatory breast cancer. Cancer Res 59 (1999) 5079-5084
5. Roberts N., Kloos B., Cassella M., et al. Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2. Cancer Res 66 (2006) 2650-2657
6. Tomlinson J.S., Alpaugh M.L., and Barsky S.H. An intact overexpressed E-cadherin/alpha, beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma. Cancer Res 61 (2001) 5231-5241
7. Tsuchiya A., Kanno M., and Abe R. The impact of lymph node metastases on the survival of breast cancer patients with ten or more positive lymph nodes. Jpn J Surg 27 (1997) 902-906
8. Jones S.E., Moon T.E., Bonadonna G., et al. Comparison of different trials of adjuvant chemotherapy in stage II breast cancer using a natural history data base. Am J Clin Oncol 10 (1987) 387-395